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Abstract
The large conductance, voltage- and calcium-dependent potassium (BK) channel serves as a major negative feedback
regulator of calcium-mediated physiological processes and has been implicated in muscle dysfunction and neurological
disorders. In addition to membrane depolarization, activation of the BK channel requires a rise in cytosolic calcium.
Localization of the BK channel near calcium channels is therefore critical for its function. In a genetic screen designed to
isolate novel regulators of the Caenorhabditis elegans BK channel, SLO-1, we identified ctn-1, which encodes an a-catulin
homologue with homology to the cytoskeletal proteins a-catenin and vinculin. ctn-1 mutants resemble slo-1 loss-of-
function mutants, as well as mutants with a compromised dystrophin complex. We determined that CTN-1 uses two distinct
mechanisms to localize SLO-1 in muscles and neurons. In muscles, CTN-1 utilizes the dystrophin complex to localize SLO-1
channels near L-type calcium channels. In neurons, CTN-1 is involved in localizing SLO-1 to a specific domain independent
of the dystrophin complex. Our results demonstrate that CTN-1 ensures the localization of SLO-1 within calcium
nanodomains, thereby playing a crucial role in muscles and neurons.
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Introduction
Precise control of membrane excitability, largely determined
by ion channels, is of utmost importance for neuronal and
muscle function. The regulation of ion channel localization,
density and gating properties thus provides an effective way to
control the excitability within these cells [1]. Indeed, the
localization and gating properties of ion channels are often
regulated or modified by cytoskeletal and signaling proteins, or
auxiliary ion channel subunits expressed in a cell-type specific
manner [2]. Potassium channels are critical in determining the
excitability of cells, because potassium ions are dominant charge
carriers at the cell resting potential. Among potassium channels,
the large conductance, voltage- and calcium-dependent potassi-
um BK channels (also called SLO-1 or Maxi-K) are uniquely
gated by coincident calcium signaling and membrane depolar-
ization [3,4]. This feature of BK channels provides a crucial
negative feedback mechanism for calcium-induced functions,
and plays an important role in determining the duration of
action potentials [3]. BK channels are widely expressed in a
variety of cell types and are implicated in many physiological
processes, including the regulation of blood pressure [5],
neuroendocrine signaling [6], smooth muscle tone [7], and
neural network excitability [8,9].
Mounting evidence indicates that BK channels can interact with
a variety of proteins that modulate channel function, or control
membrane trafficking. For example, the Drosophila BK channel,
dSLO, interacts with SLO binding protein (slob), which in turn
modulates the channel gating properties [10]. Similarly, mamma-
lian BK channels associate with auxiliary beta subunits that
influence channel activation time course and voltage-dependence
[11]. In yeast two hybrid screens, the cytoplasmic C-terminal tail
of mammalian BK channels has been shown to interact with
several proteins, including cytoskeletal elements, such as actin-
binding proteins [12,13] and a microtubule-associated protein
[14]. These cytoskeletal proteins are partially co-localized with BK
channels, and appear to increase cell surface expression of BK
channels in cultured cells [12,13]. However, it remains to be
determined whether these proteins have any role in controlling the
localization of BK channels to specific areas of the plasma
membrane in vivo. Robust activation of BK channels requires
higher intracellular calcium concentrations (.10 mM), which only
occur in the immediate vicinity of calcium-permeable channels
[4]. Hence, the localization of BK channels to specific areas (i.e.
calcium nanodomains) where calcium-permeable ion channels are
located is physiologically important for BK channel activation.
In C. elegans, loss-of-function mutations in slo-1 partially compen-
sate for the synaptic release defects of C. elegans syntaxin (unc-64)
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studies in C. elegans have also implicated SLO-1 in muscle function
[17]. slo-1 mutants display an exaggerated anterior body angle,
referred to as the head-bending phenotype that is shared by mutants
that are defective in the C. elegans dystrophin complex [18–20].
Recent evidence that the C. elegans dystrophin complex interacts with
SLO-1 channels via SLO-1 interacting protein, ISLO-1, explains this
phenotypic overlap [21]. However, C. elegans dystrophin complex
mutants do not appear to alter the biophysical properties of BK
channels per se [17]. Similarly, ISLO-1 does not modify SLO-1
channel properties [21]. Rather, ISLO-1 tethers SLO-1 near the
dense bodies of muscle membranes, where L-type calcium channels
(EGL-19) are localized [21]. Consequently, defects in the dystrophin
complexorISLO-1causealargereductioninSLO-1proteinlevelsin
muscle membrane, which in turn causes muscle hyper-excitability
leading to enhanced intracellular calcium levels. This perturbation of
calcium homeostasis has been postulated to be one of the first steps in
the degenerative muscle pathogenesis associated with disruption of
the dystrophin complex [22].
In this study, we performed a forward genetic screen to identify
additional genes responsible for SLO-1 localization and function
in C. elegans. We identified ctn-1, an orthologue of a-catulin, as a
novel gene that controls SLO-1 localization and function in
muscles and neurons. Our analysis showed that ctn-1 uses different
strategies to localize SLO-1 in these two cell types. In muscles,
CTN-1 utilizes the dystrophin complex to localize SLO-1 near L-
type calcium channels via ISLO-1. In neurons, CTN-1 localizes
SLO-1 independent of the dystrophin complex.
Results
A geneticscreenforsuppressormutants of gain-of-function
slo-1identifies genes that interact with the dystrophin gene
Loss-of-function slo-1 mutants exhibit a jerky locomotion and
head bending phenotype [15]. By contrast, gain-of-function slo-1
mutants exhibit sluggish movement combined with low muscle
tone [16]. When slo-1(gf) mutant animals are mechanically
stimulated, they fail to make a normal forward movement, and
tend to curl ventrally (Video S1). To identify genes that regulate
slo-1 function, we performed a forward genetic screen to isolate
mutants that suppress the phenotypes of the slo-1(ky399) gain-of-
function mutant. Based on a previous genetic study [21],
suppressor genes were expected to encode slo-1, components of
the dystrophin complex, as well as novel proteins that control
neuronal or muscular function of SLO-1. As expected, several loss-
of-function alleles of slo-1 were isolated. In addition to these
intragenic suppressors, several mutants could be segregated away
from slo-1(gf) (Figure 1A and Video S1) and exhibited the head
bending phenotype. Genetic mapping and complementation
testing determined that these extragenic suppressors include dyb-
1 and stn-1 which encode two homologous components of the
dystrophin complex, dystrobrevin and syntrophin respectively.
Additionally we isolated cim6 and eg1167 suppressors that
represent novel genes. Compared to slo-1(ky399) and cim6;slo-
1(ky399) mutants, eg1167;slo-1(ky399) mutants exhibited a profound
improvement in the locomotion speed (Figure 1A).
It was previously observed that slo-1(gf) mutants retain
significantly more eggs than wild-type animals due to low activity
of the egg-laying muscles [16]. We found that suppressor mutants
abolish an egg laying defect of slo-1(gf) mutants and retain eggs in
uteri at levels similar to wild-type animals (Figure 1B).
ctn-1 encodes an a-catulin orthologue that has
homology to a-catenin and vinculin
To understand the role of novel genes in slo-1 function, we
pursued the identification of genes that mapped to chromosomal
locations neither previously implicated in BK channel function, nor
encoding known components of the dystrophin complex. Two
mutations, cim6 and eg1167, both mapped to the left side of
chromosome I and failed to complement each other for head
bending, suggesting that these two mutations represent alleles of the
same gene. Our quantitative analysis for locomotion and egg laying
phenotypes showedthat the locomotionspeedofeg1167;slo-1(gf)was
higher than that of cim6;slo-1(gf) whereas egg laying was comparable
in both strains (Figure 1A and 1B). We further mapped eg1167 to a
250 kb interval and rescued the phenotype of eg1167 by generating
transgenic animals with the fosmid WRM0621cC01 (Figure S1).
Next, we rescued the head bending phenotype of eg1167 with a
transgene consisting of the ctn-1 gene (Y23H5A.5) and approxi-
mately 4 kb upstream of the translation initiation codon (Figure 2A
and 2B). The same transgene caused eg1167;slo-1(gf) double mutants
to revert to the slo-1(gf) phenotype, displaying sluggish movement
and retention of late-staged eggs in uteri (Figure 2C and 2D). These
results indicate that a genetic defect in ctn-1 is responsible for
suppression of the slo-1(gf) phenotypes.
The ctn-1 gene is orthologous to mammalian a-catulin (39.4%
identity to human a-catulin), and is named on the basis of
sequence similarity to both a-catenin and vinculin (Figure 2A)
[23]. Vinculin and a-catenin are membrane-associated cytoskel-
etal proteins found in focal adhesion plaques and cadherens
junctions. In C. elegans, vinculin (DEB-1) is localized to the dense
bodies of body wall muscle and is essential for attachment of actin
thin filaments to the sarcolemma [24], whereas a-catenin (HMP-1)
is localized to hypodermal adherens junctions and is essential for
proper enclosure and elongation of the embryo [25]. Based on its
homology to vinculin/a-catenin and the localization of mamma-
lian a-catulin [26], CTN-1 is likely to interact with other
cytoskeletal proteins, which may in turn affect SLO-1 function.
Additionally, the ctn-1 gene encodes a predicted coiled-coil
Author Summary
Calcium ions are essential for many physiological process-
es, including neurosecretion and neuronal and muscle
excitation. Paradoxically, abnormal accumulation of calci-
um ions is associated with cell death and has been
documented as an early event in muscle and neural
degenerative diseases. One mechanism to avoid detrimen-
tal calcium accumulation is to link the calcium increase
with activation of calcium-dependent potassium ion
channels, thereby reducing cell excitability and preventing
further calcium influx. This negative feedback requires
these potassium channels to be localized in close
proximity to sites of calcium entry. In a Caenorhabditis
elegans genetic screen, we identified a-catulin, known as a
cytoskeletal regulatory protein in mammals, important for
the localization of calcium-dependent potassium channels
in both muscles and neurons. In muscle, a-catulin controls
the localization of the dystrophin complex, a multimeric
protein complex implicated in muscular dystrophy. The
dystrophin complex in turn tethers the calcium-dependent
potassium channels near calcium channels. In neurons, the
a-catulin-mediated localization of the potassium channels
is independent of the dystrophin complex. Lack of a-
catulin results in mislocalization of the potassium channels,
and in turn causes defects in neuromuscular function. Our
results support the idea that cytoskeletal proteins function
as anchor molecules that localize ion channels to specific
cellular domains.
An a-catulin Homologue Regulates BK Channels
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between dystrophin and dystrobrevin [27], two components of the
dystrophin complex, although we do not know if the coiled-coil
domain of CTN-1 is important for the interaction with these
proteins (Figure 2A).
We determined nucleotide sequence of the predicted exons and
exon-intron boundaries of the ctn-1 gene in eg1167 and cim6. The
mutation sites found in both alleles create translation-termination
codons (R144.STOP in eg1167, Q521.STOP in cim6)
(Figure 2A). eg1167 exhibits complete suppression of slo-1(gf )
phenotypes (see below) and is hence considered as a severe loss-of-
function or null allele. All subsequent experiments were carried
out with eg1167, unless mentioned otherwise. Although both
eg1167 and cim6 mutants alone exhibit the head-bending
Figure 1. A genetic screen for slo-1(gf) suppressor mutants yields genes encoding components of the dystrophin complex and a
novel gene. (A) The average speed of mutants identified in a genetic screen for suppressors of slo-1(gf). dyb-1, a dystrobrevin homolog; dys-1,a
dystrophin homolog; stn-1, a syntrophin homolog. Error bars represent s. e. m. (n.10). Asterisks represent significant difference (P,0.05). (B) The
number of eggs retained in uteri of slo-1(gf) suppressor mutants. Error bars represent s. e. m. Data points between slo-1(gf) and all of other strains are
significantly different (P,0.001). (C) Quantitative analysis for the first angle of head bending. Each data set for the first angle is significantly different
from that of wild-type animals (P,0.01). Yellow dots indicate the five most anterior of the 13 midline points for a wild-type animal (See also Materials
and Methods). Error bars represent s. e. m. (n=10).
doi:10.1371/journal.pgen.1001077.g001
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phenotypes. Whereas ctn-1(eg1167) suppresses all aspects of the slo-
1(gf) phenotype, ctn-1(cim6) completely suppresses the egg-laying
defect of slo-1(gf) (Figure 1B), but not the locomotory defect
(Figure 1A). These results suggest that the C-terminal third of
CTN-1 is required for normal egg laying and head bending, but is
not necessary to mediate the locomotion speed defect of slo-1(gf)
mutants.
To elucidate the function of CTN-1, we examined the
expression pattern of the ctn-1 gene using a ctn-1 promoter-tagged
GFP reporter (Figure 2E–2H). We observed GFP fluorescence in
body wall muscles, pharyngeal muscle, egg-laying muscle and
enteric muscle of transgenic animals as well as in most, if not all,
neurons of the nerve ring and ventral nerve cord.
CTN-1 has two distinct functions in neurons and muscles
Based on the ctn-1 expression pattern and the phenotypic
differences between eg1167 and cim6, we investigated whether the
head-bending phenotype and the suppression of sluggish move-
ment of slo-1(gf) mutants are separable by expressing ctn-1
minigenes under the control of either muscle- or neuron-specific
promoters in ctn-1 and ctn-1;slo-1(gf) mutant animals. Muscle, but
not neuronal, expression of ctn-1 rescued the head-bending
phenotype of the ctn-1 mutant (Figure 2B and Figure S1C). These
results are consistent with previous reports that the head-bending
phenotype is due to perturbations in muscle function [17–19].
Furthermore, muscle expression of ctn-1 in ctn-1;slo-1(gf) mutants
resulted in egg retention to the level observed in slo-1(gf) mutants,
whereas neuronal expression of ctn-1 did not alter the number of
eggs retained in the uteri of ctn-1;slo-(gf) mutants (Figure 2C).
Conversely, neuronal expression of ctn-1 in ctn-1;slo-1(gf) mutants
reverted the seemingly normal locomotion of ctn-1;slo-1(gf) to the
sluggish, uncoordinated locomotion of the slo-1(gf) mutant,
whereas muscle expression of ctn-1 did not (Figure 2D). These
results indicate that the sluggish, uncoordinated locomotory
phenotype of slo-1(gf) mutants comes from presynaptic depression,
but not from direct suppression of muscle excitability. Together
with the allele specific phenotypic differences indicating different
regions of CTN-1 are required for normal locomotory speed and
head bending, these results suggest that CTN-1 uses two distinct
mechanisms for mediating SLO-1 function in muscle and neurons
by interacting with different sets of genes.
CTN-1 controls the integrity of the dystrophin complex
and the localization of SLO-1 in muscle
Most, if not all, of the mutants that exhibit the head bending
phenotype have a defect in either a component of the dystrophin
complex or proteins that interact with the dystrophin complex
[17–19]. The dystrophin complex is localized near muscle dense
bodies [21]. Because ctn-1 mutants exhibit the head bending
phenotype, we determined the subcellular localization of CTN-1
using a GFP-tagged CTN-1 transgene, which rescues the head
bending phenotype (data not shown). GFP::CTN-1 exhibited a
punctate expression pattern that resembled that of the dense
bodies (Figure 3A). To further define the localization of CTN-1,
we stained GFP-tagged CTN-1 transgenic animals with GFP
antibodies and vinculin/DEB-1 antibodies that recognize the
attachment plaque and dense bodies. CTN-1::GFP is localized in
close proximity to, or partially colocalized with, vinculin/DEB-1
in dense bodies, but not in the attachment plaques, indicating that
CTN-1 is localized near dense bodies (Figure 3A). This expression
pattern of CTN-1, along with the head bending phenotype of ctn-1
mutants, prompted us to examine whether the ctn-1 mutation
disrupts the integrity of the dystrophin complex. We compared the
expression pattern of a component of the dystrophin complex,
SGCA-1 (an a-sarcoglycan homolog) in wild-type, dys-1, slo-1 and
ctn-1 animals using a GFP-tagged SGCA-1 that rescues the head
bending phenotype of sgca-1 mutants [21] (Figure 3B).
GFP::SGCA-1 exhibited a punctate expression pattern in the
muscle membrane of wild-type and slo-1 mutant animals. By
contrast, GFP puncta were greatly diminished in dys-1 and ctn-1
mutants. These results indicate that ctn-1 is critical for maintaining
the dystrophin complex near the dense bodies.
We previously demonstrated that ISLO-1 interacts with STN-1
through a PDZ domain-mediated interaction, thereby linking
SLO-1 to the dystrophin complex [21]. Because we failed to
observe a component of the dystrophin complex in the muscle
membrane of ctn-1 mutants, we examined mCherry-tagged ISLO-
1 in the muscle membrane of wild-type and ctn-1 mutant animals.
The punctate mCherry::ISLO-1 fluorescence was observed in
wild-type muscle membranes, but was greatly reduced in ctn-1
mutant (Figure 3C). These results further strengthen the notion
that CTN-1 is required for maintaining the integrity of the
dystrophin complex.
Based on the genetic interaction between ctn-1 and slo-1, and the
observation that the integrity of the dystrophin complex and
ISLO-1 localization are disrupted in ctn-1 mutants, we hypothe-
sized that CTN-1 regulates the localization of SLO-1 in muscle.
To test this hypothesis, we examined the localization of GFP-
tagged SLO-1 in muscles of wild-type, dys-1, and ctn-1 animals
(Figure 4A and 4B). The punctate SLO-1::GFP expression pattern
in the muscle membrane of wild-type animals was greatly
diminished in the muscles of either dys-1 or ctn-1 mutant.
Interestingly, the protein levels of SLO-1::GFP were not
significantly different in wild-type, dys-1 and ctn-1 animals (Figure
S2B), indicating that mislocalized SLO-1 does not necessarily
undergo degradation. The mislocalization of SLO-1 in dys-1
Figure 2. ctn-1,a na-catulin homologue, has two distinct roles in mediating SLO-1 function. (A) The gene structure of ctn-1. Our genome
analysis indicates that unlike WormBase annotation (WS210) ctn-1 consists of 13 exons and is predicted to encode a 784 amino-acid protein (Figure
S1). The homology regions with a-catenin/vinculin I (homologous to the N-terminal talin/a-actinin-binding region of vinculin, 213 amino acids), a-
catenin/vinculin II (homologous to the C-terminal F-actin/inositol phospholipids-binding region of vinculin, 145 amino acids) and the coiled-coil
domain (35 amino acids) are depicted at the bottom of the gene structure. The mutation sites for two different alleles (eg1167 and cim6) are shown
on the top of the gene structure. The predicted amino acid sequence is available in Figure S1. (B) Rescue of the head bending phenotype with a
variety of ctn-1 constructs. Ex[ctn-1] represents the transgene carrying the genomic ctn-1 DNA extrachromosomal array. Ex[Pmyo-3ctn-1] represents the
muscle-specific myo-3 promoter-driven ctn-1 transgene, whereas Ex[PH20ctn-1] represents the neuron-specific H20 promoter-driven ctn-1 transgene.
Error bars represent s. e. m. (n=10). Single asterisks indicate significant difference between two groups (P,0.001, unpaired two-tailed t-test) whereas
ns indicates no significant difference. (C) Rescue of the defect in egg-laying muscle with a variety of ctn-1 constructs. Error bars represent s. e. m.
(n=15). Single asterisks indicate significant difference between two groups (P,0.001, unpaired two-tailed t-test) whereas ns indicates no significant
difference. (D) Rescue of the average locomotory speed with a variety of ctn-1 constructs. Error bars represent s. e. m. (n.10). Single asterisks indicate
significant difference between two groups (P,0.001, unpaired two-tailed t-test) whereas ns indicates no significant difference. (E–H) The expression
pattern of a ctn-1 promoter-tagged GFP reporter. Expression in (E) body wall muscles and the ventral cord neurons (arrowheads), (F) nerve ring
(arrowheads) and pharyngeal muscle (arrow), (G) egg-laying muscle, and (H) enteric (arrow) and sphincter (arrowhead) muscle. Scale bar, 10 mm.
doi:10.1371/journal.pgen.1001077.g002
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complex for ISLO-1 localization [21]. These results further
indicate that CTN-1 stabilizes or maintains the punctate muscle
expression of SLO-1::GFP in a dystrophin complex-dependent
manner.
CTN-1 regulates presynaptic release by controlling the
localization of SLO-1
In mammals, BK channels are found in neuronal somata,
dendrites and presynaptic terminals [28,29]. An immunoelectron
microscopy study indicates that BK channels are not homogeneous-
lydistributedinneurons,but areclustered,presumablynearcalcium
channels [30]. We addressed whether SLO-1 is evenly distributed or
clustered in C. elegans neurons by examining SLO-1::GFP. Wild-type
animals displayed patches of fluorescence along the ventral nerve
cord or near cell bodies under high magnification (Figure 4C and
4D, Figure S2). Tissue-specific rescue experiments demonstrated
that ctn-1 mediates SLO-1 function in neurons independent of the
dystrophin complex (Figure 2D). Therefore, we compared neuronal
SLO-1::GFP expression in dys-1 and ctn-1 mutant animals. The
clustered GFP expression observed along the ventral cord of both
wild-type and dys-1 mutant animals contrasted with the uniform
GFP localization in ctn-1 mutants (Figure 4C and 4D). These results
indicate that ctn-1 mutation disrupts the neuron-specific clustering of
SLO-1::GFP independent of the dystrophin complex.
SLO-1 contributes to the repolarization of the synaptic terminal
following neuronal stimulation, thereby terminating neurotrans-
mitter release. Consequently loss-of-function slo-1 mutants are
hypersensitive to the paralyzing effects of aldicarb, an acetylcho-
linesterase inhibitor, a phenotype indicative of enhanced acetyl-
choline release. Consistent with this interpretation, electrophysi-
ological recordings from neuromuscular junctions of slo-1 loss-of-
function mutants exhibit prolonged evoked synaptic responses
[15,16]. If CTN-1 regulates SLO-1 localization in motor neurons
and thus slo-1 function, we would expect ctn-1 mutants to exhibit
similar pharmacological and synaptic changes. Indeed, we found
that ctn-1 mutants were hypersensitive to aldicarb compared to
wild-type animals (Figure S3). To confirm this observation
directly, we measured synaptic responses from the neuromuscular
junctions of dissected wild-type and ctn-1 mutant animals
engineered to express channelrhodopsin-2 in motor neurons [31]
(Figure 5). Evoked synaptic responses were elicited by blue light
activation of channelrhodopsin-2 and recorded from voltage-
clamped post-synaptic body wall muscle cells. Consistent with our
pharmacological data and localization results, recordings from ctn-
1 showed prolonged evoked synaptic responses similar to those of
slo-1(lf) mutants (Figure 5B and 5C). Furthermore, muscular
expression of ctn-1 in ctn-1 mutant animals rescued the head-
bending phenotype (Figure 2B), but did not rescue prolonged
evoked synaptic responses (Figure S3B). These data strongly
suggest that altered synaptic responses of ctn-1 mutants result from
a neuronal defect.
In contrast to the slo-1(lf ) mutants, evoked responses of slo-1(gf)
mutants were short-lived (Figure 5C), and the charge integral, a
measure of total ion flux during the evoked response, was
significantly reduced (Figure 5E). Our genetic analyses demon-
strated that the ctn-1 mutation suppresses the sluggish locomotory
phenotype of slo-1(gf) mutants and disrupts SLO-1 localization
(Figure 1A, Figure 4C and 4D). If this is due to loss of neuronal
SLO-1(gf ) channels, the ctn-1 mutation should suppress the evoked
response defects of slo-1(gf). Consistent with this prediction, the
decaytimeofthectn-1;slo-1(gf)doublemutants(t1/2=6.6160.53 ms)
was significantly longer than slo-1(gf) (t1/2=3.2360.21 ms)
(Figure 5D), and the charge integral was restored to wild-type levels
(Figure 5E). Interestingly, ctn-1 mutants did not convert the decay
time of slo-1(gf) evoke responses to that of slo-1(lf),i n d i c a t i n gt h a t
residual SLO-1 function may be mediated by dispersed SLO-1
channels.
Discussion
In a genetic screen to identify novel regulators of SLO-1, we
found two alleles of ctn-1, a gene which encodes an a-catulin
orthologue. CTN-1 mediates normal bending of the anterior
body through SLO-1 localization near the dense bodies of body
wall muscles. CTN-1 also maintains normal locomotory speed
through SLO-1 localization within neurons. Based on our data,
we propose a model for ctn-1 function in localizing SLO-1
(Figure 6). In muscles, CTN-1 interacts with the dystrophin
complex. It is also possible that CTN-1 may influence the
stability of another protein that directly interacts with the dys-
trophin complex. Loss of CTN-1 function disrupts the integrity
of the dystrophin complex, thus compromising ISLO-1 and
SLO-1 localization near muscle dense bodies, where L-type
calcium channels are present. Disruption of SLO-1 localization
is expected to uncouple local calcium increases from SLO-1-
dependent outward-rectifying currents, resulting in muscle
hyper-excitation. Previous studies have shown that the head
bending phenotype, shared among mutants that have a defect in
the dystrophin complex or its associated proteins, results from
muscle hyperexcitability [17–19,32]. Our data further show that
this head-bending phenotype does not result from a synaptic
transmission defect, but from a muscle excitation and contrac-
t i o nd e f e c t .I nn e u r o n s ,S L O - 1localization is not mediated
through the dystrophin complex, suggesting that CTN-1
interacts with other proteins to localize SLO-1 to specific
neuronal domains.
Why does CTN-1 use two distinct mechanisms to localize SLO-
1 to subcellular regions of muscles and neurons? BK channels are
functionally coupled with several different calcium channels
(including voltage-gated L-type and P/Q-type calcium channels
and IP3 receptors) that are localized in different subcellular
regions [30,33,34]. Although it has not been determined whether
all of these calcium channels are functionally coupled with SLO-1
in C. elegans, these calcium channels are distributed in different
regions of neurons. For example, the L-type calcium channel
(EGL-19) is mainly expressed in the cell body and the P/Q type
calcium channel (UNC-2) is concentrated at the presynaptic
Figure 3. ctn-1 mutation disrupts normal localization of the dystrophin complex and ISLO-1. (A) An integrated transgenic line expressing
the lowest level of GFP-tagged CTN-1 was used for staining with anti-GFP (CTN-1, green) and anti-vinculin/DEB-1 (DEB-1, red) antibodies. Dashed box
area is enlarged in the bottom left of the panel (Merged) to show detail. Arrowheads indicate the attachment plaques that adhere tightly adjacent
muscle cells. Scale bar, 10 mm. (B) Transgenic animals expressing integrated GFP-tagged SGCA-1 were used to analyze the localization of SGCA-1 in
wild-type (WT), dys-1 ctn-1 and slo-1 animals. Scale bar, 10 mm. The graph shows quantified puncta intensities. Error bars, s.e.m. Wild-type vs. dys-1
(P,0.01), Wild-type vs. ctn-1 (P,0.01), Wild-type vs. slo-1 (P.0.05). (C) Transgenic animals expressing integrated mCherry-tagged ISLO-1 were used
for analyzing the localization of ISLO-1 in wild-type (WT) and ctn-1 animals. Scale bar, 10 mm. The graph shows quantified puncta intensities. Error
bars, s.e.m. Wild-type vs. ctn-1 (P,0.0001).
doi:10.1371/journal.pgen.1001077.g003
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SLO-1 channel localization near different calcium channels.
How CTN-1 interacts with the dystrophin complex in muscle
remains to be determined. It has been suggested that mammalian
a-catulin interacts with the hydrophobic C-terminus of dystrophin
resulting from alternative splicing [37]. However, the C. elegans dys-
1 gene does not encode a hydrophobic C-terminus. Thus, CTN-1
may interact with a different domain of dystrophin, or with
another component of the dystrophin complex. In this regard, it is
noteworthy that both mammalian dystrophin and C. elegans DYS-1
have multiple spectrin repeat domains, and that the N-terminal
region of vinculin which exhibits homology to that of a-catulin
(Figure S1) is known to bind the spectrin repeat domain of a-
actinin [38]. By extension, we speculate that the N-terminal region
of CTN-1 may bind the spectrin repeat domain of DYS-1 directly.
Alternatively, the coiled-coil domain of dystrophin, which is
known to interact with the coiled-coil domain of dystrobrevin [27],
may potentially bind the coiled-coil domain of CTN-1. Interest-
ingly, CTN-1 exhibits high homology to vinculin in both the N-
terminal and C-terminal regions (Figure S1B). The C-terminal
region of vinculin interacts with cytoskeletal molecules or
regulators (F-actin, inositol phospholipids and paxillin) in focal
adhesion and adherens junctions [39]. Because the C-terminal
region of CTN-1 is also necessary for normal head bending, we
speculate that this C-terminal region may be important for
tethering the dystrophin complex to other cytoskeletal proteins.
In mammalian striated muscle, dystrophin is enriched in
costameres [40] which are analogous to C. elegans dense bodies. A
costamere is a subsarcolemmal protein assembly that connects Z-
disks to the sarcolemma, and is considered to be a muscle-specific
elaboration of the focal adhesion in which integrin and vinculin are
abundant. Compromised costameres have been postulated to be an
underlying cause of several different myopathies [40]. It was
recently shown that ankyrin-B and -G recruit the dystrophin
complex to costameres [41]. Based on overall high homology of ctn-
1 to vinculin and a-catenin, we speculate that CTN-1 similarly
interacts with cytoskeletal proteins in the dense bodies, and links the
dystrophin complex to the dense bodies.
Another intriguing conclusion from our data is that loss of
CTN-1 does not completely abolish SLO-1 function. Complete
abolishment of SLO-1 function in ctn-1 mutant should alter the
decay time for evoked synaptic responses of ctn-1;slo-1(gf) to the
same degree as slo-1(lf) mutants, rather than to that of wild-type
animals (Figure 5D). Mutants including slo-1(gf), that have defects
in neural activation or membrane depolarization, are reported to
cause str-2, a candidate odorant receptor gene, to be expressed in
both AWC olfactory neurons whereas wild-type animals express
str-2 in only one of the AWC pair [42]. We find that ctn-1 mutation
does not suppress the misexpression of str-2 in both AWC neurons
in slo-1(gf) mutants, suggesting that ctn-1 mutations do not
completely abolish SLO-1 function (unpublished observations,
HK). It is thus likely that the defect in SLO-1 localization in ctn-1
mutants makes it less responsive to local calcium nanodomains
found at presynaptic terminals and dense bodies, but still able to
respond to depolarization-induced global calcium increases, albeit
at a lower level.
In conclusion, we have identified ctn-1, a gene encoding the C.
elegans homolog of a-catulin, and demonstrated that CTN-1
mediates SLO-1 localization in muscles and neurons by
dystrophin complex-dependent and -independent mechanisms,
respectively. How SLO-1 is localized to certain neuronal domains
will require further screening of slo-1(gf) suppressor mutants. Given
that proteins affecting components of the dystrophin complex are
likely to contribute to the pathogenesis of muscular dystrophy, a-




The genotypes of animals used in this study are: N2 (wild-type),
CB4856, dys-1(eg33) I, stn-1(tm795) I, ctn-1(eg1167) I, ctn-1(cim6) I,
slo-1(eg142) V, slo-1(ky399gf) V and sgca-1(tm1232) X. The following
transgenes were used in this study: cimIs1[slo-1a::GFP, rol-6(d)] [21],
cimIs5[mCherry::islo-1, ofm-1::GFP] [21],zxIs6[unc-17::chop-2(H134R)-
yfp; lin-15(+)] [31], cimIs6[GFP::sgca-1, rol-6(d)], cimEx5[ctn-1, ofm-
1::GFP], cimIs7[GFP::ctn-1, rol-6(d)], cimEx6[Pmyo-3ctn-1, Pmyo-3GFP,
ofm-1::GFP] and cimEx7[PH20ctn-1, PH20GFP,ofm-1::GFP].
Genetic screen for suppressor mutants of slo-1(ky399)
Gain-of-function slo-1(ky399) mutants were mutagenized by
exposure to 50 mM EMS (ethane methyl sulfonate) for 4 h [43].
Suppressors that suppress or ameliorate the sluggish locomotory
phenotype of slo-1(ky399gf) mutants were selected from F2 progeny
of the mutagenized animals. We screened approximately 5,000
haploid genome size for suppressor mutants and identified a total of
17 suppressor mutants. Genetic analysis of these suppressor mutants
indicates that three of these have a second mutation in the slo-1
gene. In addition, we found that eight have mutations in genes
causing head-bending phenotype (2 alleles of dyb-1, 3 alleles of stn-1
and 2 alleles of ctn-1). The remaining six mutants do not exhibit
distinct locomotory phenotypes when segregated from slo-1(gf).
Genetic mapping and cloning
For genetic mapping, slo-1(ky399) mutants were outcrossed 12
times to the CB4856 strain. The resulting strain was used for SNP
(single nucleotide polymorphism) mapping [44]. Alternatively, we
used CB4856 as a mapping strain when mapping is based on the
head-bending phenotype. For transgenic rescue, fosmid clones
purchased from Gene services Inc. (Cambridge, UK) were injected
into the gonad of ctn-1 mutant at 2 ng/ml along with ofm-1::GFP
marker (30 ng/ml). Once we rescued the head bending phenotype
of ctn-1 with a single fosmid, we rescued ctn-1 mutant with a
genomic DNA fragment encompassing the entire coding sequence
of ctn-1 and approximately 4 kb upstream of the putative
translation site.
To verify the predicted coding sequence of ctn-1, we first
performed BLAST search analysis using the genomic sequences of
C. briggsae and C. remanei. This analysis suggested that the first and
12th exons are longer than predicted in WormBase (WS208), and
that an additional exon (10
th exon) is present. Second, we
sequenced C. elegans ORF ctn-1 clone (9349620) and confirmed the
Figure 4. ctn-1 mutation impairs normal localization of SLO-1 in muscles and neurons. The same integrated array, SLO-1::GFP, was used
for this analysis in different genetic backgrounds. (A–B) Muscular localization of SLO-1::GFP in wild-type, dys-1 and ctn-1 animals. Arrowheads
represent the ventral (or dorsal) nerve cords. (B) The graph showing quantification of puncta intensities. Error bars, s.e.m. Wild-type vs. dys-1 or ctn-1
(P,0.0001). Scale bar, 10 mm. (C–D) Neuronal localization of SLO-1::GFP in wild-type, dys-1 and ctn-1 animals (See also Figure S2). Regions of the
ventral nerve cord (dashed boxes) are enlarged in the bottom left of each panel to show detail. (D) The graph showing quantification of puncta
intensities. Error bars, s.e.m. Wild-type vs. dys-1 (P.0.05), Wild-type vs. ctn-1 (P,0.0001). Scale bar, 10 mm.
doi:10.1371/journal.pgen.1001077.g004
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PLoS Genetics | www.plosgenetics.org 9 August 2010 | Volume 6 | Issue 8 | e1001077Figure 5. ctn-1 mutation suppresses defects of slo-1(gf) evoked synaptic responses at the neuromuscular junctions. (A) Representative
evoked current responses from wild-type, slo-1(gf), ctn-1;slo-1(gf), ctn-1 and slo-1(lf) animals. (B) Normalized evoked current responses from (A). (C)
Evoked amplitude response. Wild-type (n=31), slo-1(gf) (n=15), ctn-1;slo-1(gf) (n=12), ctn-1 (n=16), slo-1(lf) (n=21). There is no significant difference
between wild-type and each genotype used (P.0.05). (D) Half-time decay. Wild-type vs. slo-1(gf), P,0.05; wild-type vs. ctn-1;slo-1(gf), P.0.05; wild-
type vs. ctn-1, P,0.05; wild-type vs. slo-1, P,0.01. (E) Evoked charge integral. Wild-type vs. slo-1(gf), P,0.01.
doi:10.1371/journal.pgen.1001077.g005
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analysis of the DNA fragment obtained from RT-PCR with a
primer set (SL1 and an internal primer) and identified the trans-
splicing site which is 29 bp upstream of the newly-defined
translation initiation site. Our analysis indicates that ctn-1 encodes
a predicted protein with 784 amino acids (Figure S1B).
Constructs and transformation
The ctn-1 genomic DNA (approximately 4 kb upstream of the
promoter and the entire coding sequence) was amplified by the
expand long template PCR system (Roche Applied Science) and
used directly for rescue. For PH20ctn-1 and Pmyo-3ctn-1 constructs,
the neuron-specific H20 [45] or muscle-specific myo-3 promoter
sequences were fused to the translation initiation site of the ctn-1
genomic DNA in frame by the overlapping extension PCR
(Roche). For localization of CTN-1, we inserted the GFP sequence
to the translation initiation site of ctn-1 cDNA, and then the ctn-1
promoter sequence was inserted before the GFP sequence. The
resulting construct rescued the head-bending phenotype of ctn-1
mutants and was used for generating integrated transgenic
animals. For GFP::sgca-1 construct, the GFP sequence was inserted
in-frame right after the signal sequence of sgca-1 open-reading
frame as described previously [21]. Transgenic strains were made
as described [46] by injecting DNA constructs (2–10 ng/ml) along
with a co-injection marker DNA (pRF4(rol-6(d)) or ofm-1::GFP) into
the gonad of hermaphrodite animals at 100 ng/ml. We obtained at
least 3 independent transgenic lines for rescue, and found that all
lines show similar results.
Measurement of locomotory speed
To remove bacteria attached to animals, approximately fifteen age-
matched (30 hr after L4 stage) hermaphrodite animals for each
genotype were placed on a NGM (nematode growth medium) agar
plate without bacteria for 15 min. The animals were then placed inside
one of two copper rings embedded in a NGM plate. We found that age
of agar plate influences the speed of animals, probably because the
surface tension resulting from the liquid surrounding animals slows
down movement. We used approximately one week-old plates for our
assay, and compared with the speed of wild-type control animals.
Video frames from two different genotypes were simultaneously
acquired with a dissecting microscope equipped with Go-3 digital
camera (QImaging) for 2 min with a 500 ms interval and 20 ms
exposure. We measured the average speed of animals by using Track
Objects from ImagePro Plus (Media Cybernetics).
Measurement of the number of eggs
The activity of egg laying muscle was measured indirectly by
counting eggs retained in uteri. Single age-matched (30 hrs post-
L4) animals (total 15 for each genotype) were placed in each well
of a 96 well plate that contains 1% alkaline hypochlorite solution.
The eggshells protect embryos from dissolution by alkaline
hypochlorite. After 15 min incubation, the remaining eggs were
counted in each well.
Body curvature analysis
Body curvature analysis was previously described [47]. A single
animal was transferred to an agar plate and its movement was
Figure 6. A model for CTN-1 function. In muscles, CTN-1 interacts with the dystrophin complex. ISLO-1 links the dystrophin complex to SLO-1.
The N-terminal region or the coiled-coiled domain of CTN-1 is likely to interact with the dystrophin complex. The C-terminal region may interact with
other cytoskeletal proteins. In neurons, CTN-1 interacts with SLO-1 through possible unknown intermediates other than the dystrophin complex.
doi:10.1371/journal.pgen.1001077.g006
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within 15 to 60 seconds after transfer, because the head bending
phenotype is prominent when animals are stimulated to move
forward rapidly. A custom-written software automatically recog-
nizes the animal and assigns thirteen points spaced equally from
the tip of nose to the tail along the midline of the body, and
produces the pixel coordinates of thirteen points. First supple-
mentary angles were calculated from the coordinates of the first
three points with MATLAB software. First angle data were
obtained when the head swing of an animal reached the maximal
extension to the dorsoventral side.
Western blot analysis
Mixed stage worms were washed and collected in M9 buffer.
Equal volume of 26 Laemmli sample buffer was added to the
worm pellets. The resulting worm suspension was heated at 90 uC
for 10 min, centrifuged at 20,000 g for 10 min, and then
immediately loaded on 7.5% SDS-PAGE gel. The Western blot
analysis was performed using anti-GFP antibody (Clontech, JL-8)
and anti-a-tubulin antibody (Developmental hybridoma bank,
AA4.3).
Microscopy imaging
Fixation and immunostaining procedures are previously de-
scribed [21]. Fluorescence images were observed under a Zeiss
Axio Observer microscope with 406objective (water-immersion,
NA: 1.2) or an Olympus Fluoview 300 confocal microscope with a
606 objective (oil-immersion, NA: 1.4) or 1006 objective (oil-
immersion, NA: 1.4). We typically observed more than 50 animals
for each genotype. Images for quantification were acquired under
an identical exposure time, gains and pinhole diameter. The
intensity of puncta from acquired images was analyzed using
linescan (Metamorph, Molecular Devices) and presented as values
obtained by subtracting background levels from the peak grey
levels of puncta.
Electrophysiological recordings
Electrophysiological methods were as previously described [48].
Briefly, animals raised on 80 mM retinal plates, were immobilized
with cyanoacrylic glue and a lateral cuticle incision was made to
expose the ventral medial body wall muscles. Muscle recordings
were made in the whole-cell voltage-clamp configuration (holding
potential 260 mV) using an EPC-10 patch-clamp amplifier and
digitized at 2.9 kHz. The extracellular solution consisted of (in
mM): NaCl 150; KCl 5; CaCl2 5; MgCl2 4, glucose 10; sucrose 5;
HEPES 15 (pH 7.3, ,340mOsm). The patch pipette was filled
with (in mM): KCl 120; KOH 20; MgCl2 4; (N-tris[Hydrox-
ymethyl] methyl-2-aminoethane-sulfonic acid) 5; CaCl2 0.25;
Na2ATP 4; sucrose 36; EGTA 5 (pH 7.2, ,315mOsm). All of
the animals carry a transgene (zxIs6) that expresses channelrho-
dopsin-2 under the control of the cholinergic motor neuron (unc-
17)-specific promoter. Evoked currents were recorded in a body-
wall muscle after eliciting neurotransmitter release by a 10 ms
illumination using a 470 nm LED (Thor labs) triggered with a
TTL pulse from the EPC10 pulse generator [31]. Evoked post-
synaptic responses were acquired using Pulse software (HEKA)
run on a Dell computer. Subsequent analysis and graphing was
performed using Pulsefit (HEKA), Mini analysis (Synaptosoft Inc)
and Igor Pro (Wavemetrics). The data were analyzed with one-
way ANOVA followed by Dunnett’s multiple comparison.
Supporting Information
Figure S1 Genetic mapping and cloning of ctn-1. (A) SNP used
for mapping is indicated on top. The fosmid clones used for rescue
experiments are listed. (B) The predicted amino acid sequence of
ctn-1. The mutation sites within predicted amino acid sequence of
ctn-1 are indicated as bold. Overall identity of CTN-1 to human a-
catulin is 39.4%. The parts of CTN-1 amino acid sequence
exhibiting identity to human vinculin are underlined. (C) Muscle
specific expression of ctn-1 rescues the head bending phenotype of
cim6 mutants. First angles of body curvature are shown from
different genotypes of animals. ns represents no significant
difference (P.0.05).
Found at: doi:10.1371/journal.pgen.1001077.s001 (0.78 MB TIF)
Figure S2 GFP::SLO-1 expression is detected in neuronal cell
bodies, and its expression levels are not altered in wild-type and
ctn-1 mutant animals. (A) GFP::SLO-1 expression near cell body of
neurons. Arrows indicate right and left side of the ventral nerve
cord. Arrowheads indicate patched expressions of GFP::SLO-1
near cell body. Scale bar, 10 mm. (B) The expression of SLO-
1::GFP was not altered in wild-type and mutant animals. Wild-
type animals without the SLO-1::GFP transgene (control), and wild-
type (wild-type), dys-1 (dys-1)o rctn-1 (ctn-1) animals with the slo-
1::GFP transgene were used for Western blot analysis (WB).
Found at: doi:10.1371/journal.pgen.1001077.s002 (1.44 MB TIF)
Figure S3 ctn-1 is aldicarb sensitive, and has a neuronal
function. (A) The aldicarb sensitivity of slo-1(if) and ctn-1. Twenty
age-matched animals in triplicate were placed on a plate
containing 0.5 mM aldicarb, and their paralysis was scored over
a three-hour period. Error bars represent s. e. m. Asterisk indicates
significant difference between two groups (P,0.05). (B) Muscle
expression of ctn-1 does not rescue prolonged synaptic responses of
the ctn-1 mutant. Wild-type (n=31), ctn-1 (n=16), ctn-1;zxI-
s6;Ex[Pmyo-3ctn-1,P myo-3GFP, ofm-1::GFP] (n=7). Asterisks indicate
significant difference whereas ns represents no significant differ-
ence (P,0.05).
Found at: doi:10.1371/journal.pgen.1001077.s003 (0.72 MB TIF)
Video S1 Locomotory behavior of slo-1(ky399gf) and slo-
1(ky399);eg1167. A movie from slo-1(ky399gf) (Left side) and slo-
1(ky399);eg1167 (Right side). Mutation in ctn-1 suppresses the
sluggish movement of slo-1(ky399gf) animals.
Found at: doi:10.1371/journal.pgen.1001077.s004 (1.75 MB
MOV)
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